Clinical Trial Update: NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating NADPH oxidase correction in mRNA-transfected granulocyte-enriched cells for Chronic Granulomatous Disease. Recruitment is o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Chronic Granulomatous Disease, Infection | Phase 1 | Status: RECRUITING